Comparative Medico-Legal Frameworks for Psilocybin Regulation: A March 2026 Update
Preprints.org April 20, 2026 Octavian Victor Brinzei preprint
Medical regulation of psilocybin-assisted therapy has expanded internationally in the past year, with new or clarified regulatory pathways in New Zealand, Germany, Switzerland, the Czech Republic, and at the U.S. federal level. Within the United States, Utah and New Mexico have joined Oregon and Colorado in establishing lawful medical access pathways. These developments build on earlier reforms in Alberta, Canada, and Australia, where structured psychiatric prescribing frameworks were implemented. This update consolidates recent statutory amendments and regulatory decisions to provide a current comparative overview of jurisdictions permitting lawful medical use of psilocybin, distinguishing comprehensive medical regulation from restricted or exceptional access schemes.